Do-Yoon Kang, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. [SEE] Imaging for Complex PCI : Where We Are and Where We Go
  2. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  3. OCT vs. IVUS in Complex PCI: Data from the OCTIVUS Trial
  4. Current Status of TEER in Korea : AMC Experience
  5. Lesion Selection is the Key to Success of CTO PCI - Antegrade Approach Is Enough in AMC Experience
  6. Korean Experiences of Mitraclip
  7. OCTIVUS Trial
  8. Routine Functional Testing or Standard Care in High-Risk Patients after PCI
  9. Inter-Racial Differences in Characteristics and Outcomes After TAVR: TP-TAVR Registry
  10. How to Manage LM ISR?
  11. Up-to-date TAVR Data from AMC (TP TAVR, ADAPT-TAVR, ASAN TAVR Registry)
  12. Practical Approach to the Calcified Lesion PCI - When Do We Have to Consider Rotational Atherectomy?
  13. OCT vs. IVUS: When, How, Why?
  14. Case 3. Bifurcation
  15. My Approach to Intracoronary Imaging - Master\'s Skill Secret
  16. Practical Approach to the Calcified Lesion PCI
  17. How to Perform the Optimal Two Stenting in Non-LM Bifurcation?
  18. Optimal MSA for LM Crush Technique: New Criteria from AMC
  19. Recent Clinical Data Update of MitraClip
  20. Mitraclip 을 위한 시술실 준비, Puncture to Close
  21. Early Discharge After TAVR : Korean Experience After TAVR
  22. When and How to Use Intracoronary Imaging in My Cath Lab
  23. How to Optimize the LM Bifurcation PCI?: LM-IVUS Criteria
  24. Updated Imaging-Guided ISR PCI 2021
  25. Action Plan: Device Stuck During Procedure (IVUS, Rota, etc)
  26. Reinforce Strategies to Improve Outcomes in POST-MI Heart Failure
  27. [Master\'s Keynote Lecture] Hand Down a Secret of ISR PCI
  28. OCT Versus IVUS for Complex PCI
  29. Tear of Coronary Artery - Coronary Dissection
  30. Dedicated CT Algorithm for Optimal TAVR
  31. Intravascular Imaging for Guidance of PCI for In-stent Restenosis
  32. Pharmacotherapy After TAVR: Antiplatelet or Anticoagulation Therapy
  33. Drug-Coated Balloons: Contemporary Best Indication and Future Perspective
  34. Dedicated CT Algorithm for Optimal TAVR
  35. Revisited Debulking in the Treatment of In-Stent Restenosis: ROTA-ISR Randomized Trial
  36. CT Algorithm to Avoid Permanent Pacemaker and Para-Valvular Leakage
  37. CT Algorithm for Optimal TAVR in Asan Medical Center
  38. Leaflet Thrombosis, Clinical Relevance, and Optimal Antithrombotics: Updated Review and ADAPT-TAVR Trial
  39. FIMA-DEFER Trial: ARB for Plaque Stabilization
  40. Device Sizing: CT Algorithm
  41. [TCTAP C-285] Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed Bioprosthetic Mitral Valve
  42. Provocative PREVENT Cases
  43. [TCTAP A-151] Complete Versus Incomplete Revascularization in Patients with Multivessel Coronary Artery Disease Treated with Drug-Eluting Stents
  44. [TCTAP A-047] Percutaneous Coronary Intervention Versus Coronary-Artery Bypass Grafting for Left Main Coronary Disease with Reduced Left Ventricular Ejection Fraction
  45. [TCTAP A-082] The Influence of the Diabetic Status on the Clinical Outcomes After Percutaneous Coronary Intervention in the Era of Drug Eluting Stent: 5-Year Follow-up Data from the Asan Multi-Vessel Registry